|
1
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wendt MK, Allington TM and Schiemann WP:
Mechanisms of the epithelial-mesenchymal transition by TGF-beta.
Future Oncol. 5:1145–1168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thiery JP: Epithelial-mesenchymal
transitions in cancer onset and progression. Bull Acad Natl Med.
193:1969–1979. 2009.In French.
|
|
6
|
Murai T, Yamada S, Fuchs BC, Fujii T,
Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK and Kodera
Y: Epithelial-to-mesenchymal transition predicts prognosis in
clinical gastric cancer. J Surg Oncol. 109:684–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang W, Wu Y, Yan Q, Ma F, Shi X, Zhao Y,
Peng Y, Wang J and Jiang B: Deferoxamine enhances cell migration
and invasion through promotion of HIF-1α expression and
epithelial-mesenchymal transition in colorectal cancer. Oncol Rep.
31:111–116. 2014.
|
|
8
|
Leibovich-Rivkin T, Liubomirski Y,
Bernstein B, Meshel T and Ben-Baruch A: Inflammatory factors of the
tumor microenvironment induce plasticity in nontransformed breast
epithelial cells: EMT, invasion, and collapse of normally organized
breast textures. Neoplasia. 15:1330–1346. 2013. View Article : Google Scholar
|
|
9
|
Yau WL, Lam CS, Ng L, Chow AK, Chan ST,
Chan JY, Wo JY, NG KT, Man K, Poon RT, et al: Over-expression of
miR-106b promotes cell migration and metastasis in hepatocellular
carcinoma by activating epithelial-mesenchymal transition process.
PLoS One. 8:e578822013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lili LN, Matyunina LV, Walker LD, Wells
SL, Benigno BB and McDonald JF: Molecular profiling supports the
role of epithelial-to-mesenchymal transition (EMT) in ovarian
cancer metastasis. J Ovarian Res. 6:492013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pardali K and Moustakas A: Actions of
TGF-beta as tumor suppressor and pro-metastatic factor in human
cancer. Biochim Biophys Acta. 1775:21–62. 2007.
|
|
12
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Xiao Y, Ge W, Zhou K, Wen J, Yan
W, Wang Y, Wang B, Qu C, Wu J, et al: miR-200b inhibits TGF-β
1-induced epithelial-mesenchymal transition and promotes growth of
intestinal epithelial cells. Cell Death Dis. 4:e5412013. View Article : Google Scholar
|
|
15
|
Jankowski K, Kucia M, Wysoczynski M, Reca
R, Zhao D, Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, et
al: Both hepatocyte growth factor (HGF) and stromal-derived
factor-1 regulate the metastatic behavior of human rhabdomyosarcoma
cells, but only HGF enhances their resistance to radiochemotherapy.
Cancer Res. 63:7926–7935. 2003.PubMed/NCBI
|
|
16
|
Yang P, Liang SX, Huang WH, Zhang HW, Li
XL, Xie LH, Du CW and Zhang GJ: Aberrant expression of CXCR4
significantly contributes to metastasis and predicts poor clinical
outcome in breast cancer. Curr Mol Med. 14:174–184. 2014.
View Article : Google Scholar
|
|
17
|
Bazzoni G, Dejana E and Del Maschio A:
Platelet-neutrophil interactions. Possible relevance in the
pathogenesis of thrombosis and inflammation. Haematologica.
76:491–499. 1991.PubMed/NCBI
|
|
18
|
Hwang SG, Kim KM, Cheong JH, Kim HI, An
JY, Hyung WJ and Noh SH: Impact of pretreatment thrombocytosis on
blood-borne metastasis and prognosis of gastric cancer. Eur J Surg
Oncol. 38:562–567. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Zhang HY and Xia YF: Increased
platelet count is an indicator of metastasis in patients with
nasopharyngeal carcinoma. Tumour Biol. 34:39–45. 2013. View Article : Google Scholar
|
|
20
|
Sasaki K, Kawai K, Tsuno NH, Sunami E and
Kitayama J: Impact of preoperative thrombocytosis on the survival
of patients with primary colorectal cancer. World J Surg.
36:192–200. 2012. View Article : Google Scholar
|
|
21
|
Kaneko MK, Kunita A, Abe S, Tsujimoto Y,
Fukayama M, Goto K, Sawa Y, Nishioka Y and Kato Y: Chimeric
anti-podoplanin antibody suppresses tumor metastasis through
neutralization and antibody-dependent cellular cytotoxicity. Cancer
Sci. 103:1913–1919. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blair P and Flaumenhaft R: Platelet
alpha-granules: Basic biology and clinical correlates. Blood Rev.
23:177–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chatterjee M, Huang Z, Zhang W, Jiang L,
Hultenby K, Zhu L, Hu H, Nilsson GP and Li N: Distinct platelet
packaging, release, and surface expression of proangiogenic and
antiangiogenic factors on different platelet stimuli. Blood.
117:3907–3911. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tamura S, Suzuki H, Hirowatari Y, Hatase
M, Nagasawa A, Matsuno K, Kobayashi S and Moriyama T: Release
reaction of brain-derived neurotrophic factor (BDNF) through PAR1
activation and its two distinct pools in human platelets. Thromb
Res. 128:e55–e61. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cottrell GS, Coelho AM and Bunnett NW:
Protease-activated receptors: The role of cell-surface proteolysis
in signalling. Essays Biochem. 38:169–183. 2002.PubMed/NCBI
|
|
26
|
Schaffner F and Ruf W: Tissue factor and
PAR2 signaling in the tumor microenvironment. Arterioscler Thromb
Vasc Biol. 29:1999–2004. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Xu C, Yu S, Liu P, Luo D, Zhou Q,
Gao C and Hu H: A critical role of thrombin/PAR-1 in ADP-induced
platelet secretion and the second wave of aggregation. J Thromb
Haemost. 11:930–940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujimoto D, Hirono Y, Goi T, Katayama K,
Matsukawa S and Yamaguchi A: The activation of proteinase-activated
receptor-1 (PAR1) mediates gastric cancer cell proliferation and
invasion. BMC Cancer. 10:4432010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O’Keefe SC, Marshall FF, Issa MM, Harmon
MP and Petros JA: Thrombocytosis is associated with a significant
increase in the cancer specific death rate after radical
nephrectomy. J urol. 168:1378–1380. 2002. View Article : Google Scholar
|
|
30
|
Lim SH, Becker TM, Chua W, Caixeiro NJ, Ng
WL, Kienzle N, Tognela A, Lumba S, Rasko JE, de Souza P, et al:
Circulating tumour cells and circulating free nucleic acid as
prognostic and predictive biomarkers in colorectal cancer. Cancer
Lett. 346:24–33. 2014. View Article : Google Scholar
|
|
31
|
Almog N and Klement GL: Platelet proteome
and tumor dormancy: Can platelets content serve as predictive
biomarkers for exit of tumors from dormancy? Cancers. 2:842–858.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang K, Zhao X, Kuang C, Qian D, Wang H,
Jiang H, Deng M and Huang L: Overexpression of SDF-1α enhanced
migration and engraftment of cardiac stem cells and reduced
infarcted size via CXCR4/PI3K pathway. PLoS One. 7:e439222012.
View Article : Google Scholar
|
|
33
|
Zhou H, Hu H, Shi W, Ling S, Wang T and
Wang H: The expression and the functional roles of tissue factor
and protease-activated receptor-2 on SW620 cells. Oncol Rep.
20:1069–1076. 2008.PubMed/NCBI
|
|
34
|
Bambace NM and Holmes CE: The platelet
contribution to cancer progression. J Thromb Haemost. 9:237–249.
2011. View Article : Google Scholar
|
|
35
|
Hu L, Lee M, Campbell W, Perez-Soler R and
Karpatkin S: Role of endogenous thrombin in tumor implantation,
seeding, and spontaneous metastasis. Blood. 104:2746–2751. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nishimura S, Manabe I, Nagasaki M, Seo K,
Yamashita H, Hosoya Y, Ohsugi M, Tobe K, Kadowaki T, Nagai R, et
al: In vivo imaging in mice reveals local cell dynamics and
inflammation in obese adipose tissue. J Clin Invest. 118:710–721.
2008.PubMed/NCBI
|
|
37
|
Labelle M, Begum S and Hynes RO: Direct
signaling between platelets and cancer cells induces an
epithelial-mesenchymal-like transition and promotes metastasis.
Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bae E, Kim SJ, Hong S, Liu F and Ooshima
A: Smad3 linker phosphorylation attenuates Smad3 transcriptional
activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition
in renal epithelial cells. Biochem Biophys Res Commun. 427:593–599.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiong M, Jiang L, Zhou Y, Qiu W, Fang L,
Tan R, Wen P and Yang J: The miR-200 family regulates
TGF-β1-induced renal tubular epithelial to mesenchymal transition
through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J
Physiol Renal Physiol. 302:F369–F379. 2012. View Article : Google Scholar
|
|
40
|
Brabletz S and Brabletz T: The ZEB/miR-200
feedback loop - a motor of cellular plasticity in development and
cancer? EMBO Rep. 11:670–677. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gawaz M, Langer H and May AE: Platelets in
inflammation and atherogenesis. J Clin Invest. 115:3378–3384. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Blair P and Flaumenhaft R: Platelet
α-granules: Basic biology and clinical correlates. Blood Rev.
23:177–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rothwell PM, Wilson M, Elwin CE, Norrving
B, Algra A, Warlow CP and Meade TW: Long-term effect of aspirin on
colorectal cancer incidence and mortality: 20-year follow-up of
five randomised trials. Lancet. 376:1741–1750. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lin MS, Huang JX, Zhu J and Shen HZ:
Elevation of platelet count in patients with colorectal cancer
predicts tendency to metastases and poor prognosis.
Hepatogastroenterology. 59:1687–1690. 2012.PubMed/NCBI
|
|
45
|
Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ,
Wang H, Wang Y, Li R, Yang Y, Zhao X, et al:
CD133+CXCR4+ colon cancer cells exhibit
metastatic potential and predict poor prognosis of patients. BMC
Med. 10:852012. View Article : Google Scholar
|
|
46
|
Balabanian K, Lagane B, Infantino S, Chow
KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M and
Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals
through the orphan receptor RDC1 in T lymphocytes. J Biol Chem.
280:35760–35766. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sun YX, Schneider A, Jung Y, Wang J, Dai
J, Wang J, Cook K, Osman NI, Koh-Paige AJ, Shim H, et al: Skeletal
localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis
blocks prostate cancer metastasis and growth in osseous sites in
vivo. J Bone Miner Res. 20:318–329. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu Q, Hou X, Xia J, Qian X, Miele L,
Sarkar FH and Wang Z: Emerging roles of PDGF-D in EMT progression
during tumorigenesis. Cancer Treat Rev. 39:640–646. 2013.
View Article : Google Scholar :
|
|
50
|
Devarajan E, Song YH, Krishnappa S and Alt
E: Epithelial-mesenchymal transition in breast cancer lines is
mediated through PDGF-D released by tissue-resident stem cells. Int
J Cancer. 131:1023–1031. 2012. View Article : Google Scholar
|
